The DOI matches its Crossref record; 826 of the 826 references it cites were found in a registry or an index.
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision
Open accessAbstract
In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002, World J Biol Psychiatry 3:171), recommendations for the pharmacological treatment of anxiety disorder, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are presented. Since the publication of the first version of this guideline, a substantial number of new randomized controlled studies of anxiolytics have been published. In particular, more relapse prevention studies are now available that show sustained efficacy of anxiolytic drugs. The recommendations, developed by the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-traumatic Stress Disorders, a consensus panel of 30 international experts, are now based on 510 published randomized, placebo- or comparator-controlled clinical studies (RCTs) and 130 open studies and case reports. First-line treatments for these disorders are selective serotonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs) and the calcium channel modulator pregabalin. Tricyclic antidepressants (TCAs) are equally effective for some disorders, but many are less well tolerated than the SSRIs/SNRIs. In treatment-resistant cases, benzodiazepines may be used when the patient does not have a history of substance abuse disorders. Potential treatment options for patients unresponsive to standard treatments are described in this overview. Although these guidelines focus on medications, non-pharmacological were also considered. Cognitive behavioural therapy (CBT) and other variants of behaviour therapy have been sufficiently investigated in controlled studies in patients with anxiety disorders, OCD, and PTSD to support them being recommended either alone or in combination with the above medicines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–600 of 826
Psychiatric Manifestations of Graves??? Hyperthyroidism: Pathophysiology and Treatment Options
Bunevičius, R., & Prange, A. J. (2006) · CNS Drugs · doi:10.2165/00023210-200620110-00003 · Cited by 127
Tranylcypromine in Social Phobia
Versiani, M., Mundim, F. D., Nardi, A. E., & Liebowitz, M. R. (1988) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198808000-00008 · Cited by 127
Goodman, W. K., Bose, A., & Wang, Q. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.11.011 · Cited by 126
Lydiard, R. B., Stahl, S. M., Hertzman, M., & Harrison, W. M. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n1104 · Cited by 126
Williams, S. L., & Falbo, J. (1996) · Behaviour Research and Therapy · doi:10.1016/0005-7967(95)00063-1 · Cited by 124
Rufer, M., Hand, I., Alsleben, H., Braatz, A., Ortmann, J., Katenkamp, B., Fricke, S., & Peter, H. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0544-8 · Cited by 124
Clinical Effects of Buspirone in Social Phobia: A Double-Blind Placebo-Controlled Study
van Vliet, I. M., den Boer, J. A., Westenberg, H. G. M., & Pian, K. L. H. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0405 · Cited by 124
Uncritical positive regard? Issues in the efficacy and safety of psychotherapy
Nutt, D. J., & Sharpe, M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107086283 · Cited by 123
Michelson, D., Lydiard, R. B., Pollack, M. H., Tamura, R., HOOG, S. L., Tepner, R. G., Demitrack, M. A., Tollefson, G. D., & the Fluoxetine Panic Disorder Study Group (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1570 · Cited by 123
Adjunctive Risperidone in Generalized Anxiety Disorder
Brawman‐Mintzer, O., Knapp, R. G., & Nietert, P. J. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1016 · Cited by 122
Olanzapine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder
Koran, L. M., Ringold, A. L., & Elliott, M. A. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0709 · Cited by 122
Pollack, M. H., Roy‐Byrne, P., Ameringen, M. V., Snyder, H., Brown, C. E., Ondrasik, J., & Rickels, K. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1109 · Cited by 122
Ameringen, M. V., Mancini, C., Patterson, B. A., & Bennett, M. (2005) · Depression and Anxiety · doi:10.1002/da.20118 · Cited by 121
Does EMDR Work? And if so, Why?
Cahill, S. P., Carrigan, M. H., & Frueh, B. C. (1999) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(98)00039-5 · Cited by 120
Dünner, D. L., Ishiki, D., Avery, D., Wilson, L. G., & Hyde, T. S. (1986) · PubMed · Cited by 120
Allgulander, C., Mangano, R. M., Zhang, J., Dahl, A. A., Lepola, U. M., Sjödin, I., & Emilien, G. (2004) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.602 · Cited by 120
Treatment of obsessive—compulsive disorder with fluvoxamine
Goodman, W. K., Kozak, M., Liebowitz, M. R., & White, K. L. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199603000-00003 · Cited by 120
Imipramine in the Treatment of Social Phobia
Simpson, H. B., Schneier, F. R., Campeas, R. B., Marshall, R. D., Fallon, B. A., Davies, S., Klein, D. F., & Liebowitz, M. R. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199804000-00005 · Cited by 119
Pallanti, S., Quercioli, L., & Bruscoli, M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1015 · Cited by 118
Stein, M. B., Pollack, M. H., Bystritsky, A., Kelsey, J. E., & Mangano, R. M. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1957-9 · Cited by 117
Liebowitz, M. R., Stein, M. B., Tancer, M. E., Carpenter, D. J., Oakes, R., & Pitts, C. D. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0113 · Cited by 117
Dannon, P. N., Sasson, Y., Hirschmann, S., Iancu, I., Grunhaus, L. J., & Zohar, J. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00065-1 · Cited by 116
Self-citationPollack, M. H., Lepola, U. M., Koponen, H., Simon, N. M., Worthington, J. J., Emilien, G., Tzanis, E. L., Salinas, E. O., Whitaker, T., & Gao, B. (2006) · Depression and Anxiety · doi:10.1002/da.20218 · Cited by 116
Montoya, A., Weiss, A. P., Price, B. H., Cassem, E. H., Dougherty, D. D., Nierenberg, A. A., Rauch, S. L., & Cosgrove, G. R. (2002) · Neurosurgery · doi:10.1097/00006123-200205000-00018 · Cited by 116
The treatment of postpartum depression: minimizing infant exposures.
Newport, D. J., Hostetter, A. L., Arnold, A., & Stowe, Z. N. (2002) · PubMed · Cited by 116
Montgomery, S. A., Nil, R., Dürr-Pal, N., Loft, H., & Boulenger, J.-P. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1009 · Cited by 115 · cited 2×
“Escitalopram was more effective in preventing relapses (Montgomery et al. 2005)(A).”
BackgroundResultBaldwin, D. S., Huusom, A. K. T., & Mæhlum, E. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.012799 · Cited by 114
The Expert Consensus Guideline Series. Treatment of depression in women.
Altshuler, L. L., Cohen, L. S., Moline, M. L., Kahn, D. A., Carpenter, D., & Docherty, J. P. (2001) · PubMed · Cited by 113
Pigott, T. A., L'Heureux, F., Hill, J., Bihari, K., BERNSTEIN, S. E., & Murphy, D. L. (1992) · Current Opinion in Cardiology · doi:10.1097/00001573-199202000-00003 · Cited by 113
Panic and Agoraphobia Scale (PAS).
Bandelow, B. (1999) · Cited by 113
Self-citationConlon, L., Fahy, T. J., & Conroy, R. (1999) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(98)00068-3 · Cited by 112
Treatment of obsessive‐compulsive disorder by psychosurgery
Hay, P., Sachdev, P. S., Cumming, S., Smith, J. S., Lee, T. K., Kitchener, P., & Matheson, J. M. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03356.x · Cited by 112
Paroxetine in social anxiety disorder: a randomized placebo‐controlled study
Allgulander, C. (1999) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1999.tb10845.x · Cited by 112
Olanzapine treatment for post-traumatic stress disorder: an open-label study
Petty, F., Brannan, S. K., Casada, J. H., Davis, L. L., Gajewski, V., Kramer, G. L., Stone, R. C., Teten, A. L., Worchel, J., & Young, K. A. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200111000-00003 · Cited by 112
Bradwejn, J., Ahokas, A., Stein, D. J., Salinas, E. O., Emilien, G., & Whitaker, T. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.187.4.352 · Cited by 112
Two-year follow-up of exposure and imipramine treatment of agoraphobia
MAVISSAKALIAN, M. R., & Michelson, L. K. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.9.1106 · Cited by 111
Bielski, R. J., Bose, A., & Chang, C.-C. (2005) · Annals of Clinical Psychiatry · doi:10.1080/10401230590932326 · Cited by 111
Tiagabine for the Treatment of Generalized Anxiety Disorder
Rosenthal, M. H. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1016 · Cited by 111
Fluoxetine in Social Phobia: A Double-Blind, Placebo-Controlled Pilot Study
Kobak, K. A., Greist, J. H., Jefferson, J. W., & Katzelnick, D. J. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200206000-00005 · Cited by 111
A Controlled, Prospective, 1-Year Trial of Citalopram in the Treatment of Panic Disorder
Lepola, U. M., Wade, A. G., Leinonen, E. V. J., Koponen, H., Frazer, J., Sjödin, I., Penttinen, J., Pedersen, T., & Lehto, H. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1006 · Cited by 111
An open trial of citalopram in adolescents with post-traumatic stress disorder
Seedat, S., Lockhat, R., Kaminer, D., Zungu‐Dirwayi, N., & Stein, D. J. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200101000-00002 · Cited by 111
Moclobemide in social phobia: A double-blind, placebo-controlled clinical study
Katschnig, H. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02900196 · Cited by 111
Li, X., May, R. S., Tolbert, L. C., Jackson, W. T., Flournoy, J. M., & Baxter, L. R. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0610 · Cited by 110 · cited 1×
“In a double-blind cross-over study, both haloperidol and risperidone were as effective when added to an SSRI (Li et al. 2005).”
BackgroundSousa, M. B., Isolan, L. R., Oliveira, R. R., Manfro, G. G., & Cordioli, A. V. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0717 · Cited by 110
Generalized anxiety disorder: A 40-year follow-up study
Rubio, G., & López‐Ibor, J. J. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00896.x · Cited by 110
Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders
Altamura, A. C., Pioli, R., Vitto, M. F., & Mannu, P. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199907000-00006 · Cited by 110
The Efficacy and Tolerability of Tiagabine in Adult Patients With Post-Traumatic Stress Disorder
Davidson, J. R. T., Brady, K. T., Mellman, T. A., Stein, M. B., & Pollack, M. H. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31802e5115 · Cited by 110
Bolton, D., & Perrin, S. G. (2007) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2006.11.002 · Cited by 110
WCA Recommendations for the Long-Term Treatment of Generalized Anxiety Disorder
Allgulander, C., Bandelow, B., Hollander, E., Montgomery, S., Nutt, D., Okasha, A., Pollack, M. H., Stein, D. J., & Swinson, R. P. (2003) · CNS Spectrums · doi:10.1017/s1092852900006945 · Cited by 110
Self-citationIntravenous Clomipramine for Obsessive-Compulsive Disorder Refractory to Oral Clomipramine
Fallon, B. A., Liebowitz, M. R., Campeas, R. B., Schneier, F. R., Marshall, R. D., Davies, S. O., Goetz, D., & Klein, D. F. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.10.918 · Cited by 110
Paroxetine, Clomipramine, and Cognitive Therapy in the Treatment of Panic Disorder
Bakker, A., van Dyck, R., Spinhoven, P., & van Balkom, A. J. L. M. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1205 · Cited by 109
Gould, R. A., & Clum, G. A. (1995) · Behavior Therapy · doi:10.1016/s0005-7894(05)80099-1 · Cited by 109
Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
Tesar, G. E., Rosenbaum, J. F., Pollack, M. H., Otto, M. W., Sachs, G. S., Herman, J. B., Cohen, L. S., & Spier, S. A. (1991) · PubMed · Cited by 109
LADER, M. H., & Morton, S. V. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01831.x · Cited by 109
Effect of Fluvoxamine on Panic Disorder
Hoehn‐Saric, R., McLeod, D. R., & Hipsley, P. A. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199310000-00004 · Cited by 108
Pharmacological Treatment of Agoraphobia: Imipramine versus Imipramine with Programmed Practice
MAVISSAKALIAN, M. R., Michelson, L. K., & Dealy, R. S. (1983) · The British Journal of Psychiatry · doi:10.1192/bjp.143.4.348 · Cited by 108
Palatnik, A., Frolov, K., Fux, M., & Benjamin, J. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200106000-00014 · Cited by 107
A Randomized Controlled Trial of Venlafaxine Extended Release in Generalized Social Anxiety Disorder
Liebowitz, M. R., Mangano, R. M., Bradwejn, J., & Asnis, G. M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0213 · Cited by 107
Mirtazapine versus fluoxetine in the treatment of panic disorder
Ribeiro, L. W., Busnello, J. V., Kauer‐Sant’Anna, M., Madruga, M., Quevedo, J., Busnello, E. A. D., & Kapczinski, F. P. (2001) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2001001000010 · Cited by 107
Report on the formation of the Canadian Psychiatric Association.
Gh, S. (1951) · PubMed · Cited by 106
Practitioner Review: Treatment of Obsessive-Compulsive Disorder in Children and Adolescents
Rapoport, J. L., & Inoff‐Germain, G. (2000) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.00627 · Cited by 106
Fineberg, N. A., Sivakumaran, T., Roberts, A., & Gale, T. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200507000-00005 · Cited by 105
Feske, U., & Goldstein, A. J. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.65.6.1026 · Cited by 105
No Improvement of Posttraumatic Stress Disorder Symptoms With Guanfacine Treatment
Neylan, T. C., Lenoci, M., Samuelson, K. W., Metzler, T. J., Henn-Haase, C., Hierholzer, R. W., Lindley, S. E., Otte, C., Schoenfeld, F. B., Yesavage, J. A., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.12.2186 · Cited by 105
Buspirone in the long-term treatment of generalized anxiety disorder.
Feighner, J. P. (1987) · PubMed · Cited by 105
Predicting response to amitriptyline in posttraumatic stress disorder
Davidson, J. R. T., Kudler, H. S., Saunders, W. B., Erickson, L., Smith, R., Stein, R. M., Lipper, S., Hammett, E. B., Mahorney, S. L., & Cavenar, J. O. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.7.1024 · Cited by 105
Panic disorder: treatment with valproate.
WOODMAN, C. L., & Noyes, R. (1994) · PubMed · Cited by 104
Davis, L. L., Davidson, J. R. T., Ward, L. C., Bartolucci, A., Bowden, C. L., & Petty, F. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318160f83b · Cited by 104
Survey on the Usefulness of Trazodone in Patients with PTSD with Insomnia or Nightmares
Warner, M. D., Dorn, M., & Peabody, C. A. (2001) · Pharmacopsychiatry · doi:10.1055/s-2001-15871 · Cited by 103
Romano, S. J., Goodman, W. K., Tamura, R., & Gonzales, J. S. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00009 · Cited by 103
Fineberg, N. A., Stein, D. J., Premkumar, P., Carey, P., Sivakumaran, T., Vythilingum, B., Seedat, S., Westenberg, H., & Denys, D. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000215083.57801.11 · Cited by 103 · cited 1×
“Altogether, meta-analyses demonstrated positive effects of antipsychotic augmentation (Bloch et al. 2006; Fineberg et al. 2006; Skapinakis et al. 2007).”
BackgroundHollander, E., Koran, L. M., Goodman, W. K., Greist, J. H., Ninan, P. T., Yang, H., Li, D., & Barbato, L. M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0604 · Cited by 103
Self-citationNakatani, E., Nakagawa, A., Nakao, T., Yoshizato, C., Nabeyama, M., Kudo, A., Isomura, K., Kato, N., Yoshioka, K., & Kawamoto, M. (2005) · Psychotherapy and Psychosomatics · doi:10.1159/000086317 · Cited by 102
Liebowitz, M. R., Gorman, J. M., Fyer, A. J., Campeas, R. B., Levin, A. P., Sandberg, D., Hollander, E., Papp, L. A., & Goetz, D. M. (1988) · PubMed · Cited by 102
Self-citationRapid benefit of intravenous pulse loading of clomipramine in obsessive- compulsive disorder
Koran, L. M., Sallee, F. R., & Pallanti, S. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.3.396 · Cited by 101
Weiss, E. L., Potenza, M. N., McDougle, C. J., & Epperson, C. N. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0804 · Cited by 101
Fluoxetine efficacy in social phobia.
Ameringen, M. V., Mancini, C., & Streiner, D. L. (1993) · PubMed · Cited by 101
Nagy, L. M. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110035005 · Cited by 101
Memantine for Treatment-Resistant OCD
Poyurovsky, M., Weizman, R., Weizman, A., & Koran, L. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2191-a · Cited by 101
Goldstein, A. J., de Beurs, E., Chambless, D. L., & Wilson, K. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.6.947 · Cited by 101
Maina, G., Pessina, E., Albert, U., & Bogetto, F. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.01.001 · Cited by 101
Modigh, K., Westberg, P., & Eriksson, E. (1992) · PubMed · Cited by 100
Padala, P. R., Madison, J., Monnahan, M., Marcil, W., Price, P., Ramaswamy, S., Din, A. U., Wilson, D. R., & Petty, F. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200609000-00005 · Cited by 100
Memantine augmentation for refractory obsessive–compulsive disorder
Pasquini, M., & Biondi, M. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.04.013 · Cited by 100
Outcome after the psychosurgical operation of stereotactic subcaudate tractotomy, 1979-1991
Hodgkiss, A., Malizia, A. L., Bartlett, J. R., & Bridges, P. K. (1995) · Journal of Neuropsychiatry · doi:10.1176/jnp.7.2.230 · Cited by 100
Paroxetine for social anxiety and alcohol use in dual-diagnosed patients
Randall, C. L., Johnson, M., Thevos, A. K., Sonne, S. C., Thomas, S. E., Willard, S. L., Brady, K. T., & Davidson, J. R. T. (2001) · Depression and Anxiety · doi:10.1002/da.1077 · Cited by 99
Pilot Study of Community-Based Cognitive Behavioral Group Therapy for Adolescents With Social Phobia
BAER, S., & Garland, E. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200503000-00010 · Cited by 99
Rickels, K., Mangano, R. M., & Khan, A. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000138764.31106.60 · Cited by 98
Koren, G. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041100 · Cited by 98
Royal Australian and New Zealand College Of Psychiatrists Clinical Practice Guidelines Team For Panic Disorder And Agoraphobia (2003) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2003.01254.x · Cited by 98
van Oppen, P., van Balkom, A. J. L. M., de Haan, E., & van Dyck, R. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1111 · Cited by 97
Diazepam versus alprazolam for the treatment of panic disorder.
Noyes, R., Burrows, G. D., Reich, J. H., Judd, F. K., Garvey, M. J., Norman, T. R., Cook, B. L., & Marriott, P. F. (1996) · PubMed · Cited by 97
Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia
Ameringen, M. V., Mancini, C., & Wilson, C. (1996) · Journal of Affective Disorders · doi:10.1016/0165-0327(96)00030-4 · Cited by 97
McGee, M. D. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0106e · Cited by 97
Placebo-Controlled, Multicenter Study of Sertraline Treatment for Obsessive-Compulsive Disorder
Kronig, M. H., Apter, J. T., Asnis, G. M., Bystritsky, A., Curtis, G., Ferguson, J. M., Landbloom, R. P., Munjack, D. J., Riesenberg, R. A., Robinson, D. G., et al. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199904000-00013 · Cited by 97
Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system
Stahl, M. M. S., Lindquist, M., Pettersson, M., Edwards, I. R., Sanderson, J. H., Taylor, N. F. A., Fletcher, A. P., & Schou, J. S. (1997) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050357 · Cited by 97
Valproic Acid and Panic Disorder
Primeau, F. J., Fontaine, R., & Beauclair, L. (1990) · The Canadian Journal of Psychiatry · doi:10.1177/070674379003500309 · Cited by 96
Cottraux, J. A., Mollard, E., Bouvard, M. A., & Marks, I. M. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90030-k · Cited by 96
Bilateral Anterior Capsulotomy for Refractory Obsessive-Compulsive Disorders
Oliver, B., Gascón, J., Aparicio, A., Ayats, E., Rodríguez, R. R., de León, J. L. M., García-Bach, M., & Soler, P. A. (2003) · Stereotactic and Functional Neurosurgery · doi:10.1159/000075110 · Cited by 96
Stein, M. B., Sareen, J., Cissell, S. H., & Chao, J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1725 · Cited by 96
A Randomized Controlled Clinical Trial of Psychoanalytic Psychotherapy for Panic Disorder
Milrod, B. L. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.164.2.265 · Cited by 96
Efficacy of telephone-administered behavioral therapy for panic disorder with agoraphobia
Swinson, R. P., Fergus, K. D., Cox, B. J., & Wickwire, K. (1995) · Behaviour Research and Therapy · doi:10.1016/0005-7967(94)00061-n · Cited by 95
Flawed Meta-Analyses Comparing Psychotherapy With Pharmacotherapy
Klein, D. F. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.8.1204 · Cited by 95
Fux, M., Benjamin, J., & Belmaker, R. H. (1999) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145799001546 · Cited by 95
Escitalopram prevents relapse of obsessive-compulsive disorder
Fineberg, N. A., Tonnoir, B., Lemming, O. M., & Stein, D. J. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.11.005 · Cited by 95
Vogel, P. A., Stiles, T. C., & Götestam, K. G. (2004) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465804001353 · Cited by 94 · cited 1×
“1995), whereas CBT and ERP were found to be equal in other studies (McLean et al. 2001; Vogel and Gotestam 2004; Whittal et al. 2005).”
ResultLithium and tryptophan augmentation in clomipramine-resistant obsessive- compulsive disorder
Rasmussen, S. A. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.10.1283 · Cited by 94
Albert, U., Aguglia, E., Maina, G., & Bogetto, F. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1108 · Cited by 94
Valproate treatment of panic disorder and lactate-induced panic attacks
Keck, P. E., Taylor, V. E., Tugrul, K. C., McElroy, S. L., & Bennett, J. A. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90010-b · Cited by 94
Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives
Connor, K. M., & Davidson, J. R. T. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00285-6 · Cited by 94
Clayton, P. J. (1990) · PubMed · Cited by 94
Bisserbe, J. C., Lane, R. M., Flament, M. F., & France-Belgian OCD Study Group (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)89646-0 · Cited by 93
Koponen, H., Allgulander, C., Erikson, J., Dunayevich, E., Pritchett, Y., Detke, M. J., Ball, S. G., & Russell, J. M. (2007) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v09n0203 · Cited by 93
Living with Marfan syndrome I. Perceptions of the condition
Peters, K., Kong, F., Horne, R., Francomano, C., & Biesecker, B. B. (2001) · Clinical Genetics · doi:10.1034/j.1399-0004.2001.600405.x · Cited by 92
Superiority of Clomipramine over Imipramine in the
Modigh, K., Westberg, P., & Eriksson, E. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199208000-00007 · Cited by 92
Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention
Bandelow, B., Wedekind, D., & León, T. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.7.769 · Cited by 92
Self-citationCognitive behavior therapy for treatment-refractory panic disorder.
Pollack, M. H., Otto, M. W., Kaspi, S. P., Hammerness, P. G., & Rosenbaum, J. F. (1994) · PubMed · Cited by 91
Neurobiology of Generalized Anxiety Disorder
Jetty, P. V., Charney, D. S., & Goddard, A. W. (2001) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70207-0 · Cited by 91
Brain mechanisms of social anxiety disorder.
Nutt, D., Bell, C., & Malizia, A. L. (1998) · PubMed · Cited by 90
Ravizza, L., Barzega, G., Bellino, S., Bogetto, F., & Maina, G. (1996) · PubMed · Cited by 90
St John??s wort versus placebo in obsessive???compulsive disorder: results from a double-blind study
Kobak, K. A., Taylor, L. V. H., Bystritsky, A., Kohlenberg, C. J., Greist, J. H., Tucker, P. M., Warner, G., Futterer, R., & Vapnik, T. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200511000-00003 · Cited by 90
Psychological Treatment of Chronic Posttraumatic Stress Disorder in Victims of Sexual Aggression
Echeburúa, E., de Corral, P., Zubizarreta, I., & Sarasua, B. (1997) · Behavior Modification · doi:10.1177/01454455970214003 · Cited by 90
Hirschmann, S., Dannon, P. N., Iancu, I., Dolberg, O. T., Zohar, J., & Grunhaus, L. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200010000-00011 · Cited by 89
Self-citationThomsen, P. H. (1997) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1997.7.157 · Cited by 89
Pharmacotherapy for post traumatic stress disorder (PTSD)
Stein, D. J., Zungu‐Dirwayi, N., van der Linden, G. J., & Seedat, S. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002795 · Cited by 88
Muehlbacher, M., Nickel, M. K., Nickel, C., Kettler, C., Lahmann, C., Gil, F. P., Leiberich, P. K., Rother, N., Bachler, E., Fartacek, R. R., et al. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000186871.04984.8d · Cited by 88
Andersch, S., Rosenberg, N., Kullingsjö, H., Ottosson, J., Bech, P., Bruun‐Nansen, J., Hanson, L. G., Lorentzen, K., Mellergård, M., Rasmussen, S., et al. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb03097.x · Cited by 88
Duration of antidepressant use during pregnancy and risk of major congenital malformations
Ramos, É., St‐André, M., Rey, É., Oraichi, D., & Bérard, A. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.042523 · Cited by 88
Pharmacoeconomics of antipsychotic drug therapy.
Hargreaves, W. A., & Shumway, M. (1996) · PubMed · Cited by 88
Kampman, M., Keijsers, G. P. J., Hoogduin, C. A. L., & Hendriks, G.-J. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0904 · Cited by 87 · cited 1×
“Conversely, SSRIs or clomipramine can improve patients who responded insufficiently to CBT, according to placebo-controlled studies (Hoffart et al. 1993; Kampman et al. 2002).”
BackgroundCognitive behaviour therapy and medication in the treatment of obsessive–compulsive disorder
O’Connor, K. P., Aardema, F., Robillard, S., Guay, S., Pélissier, M., Todorov, C., Borgeat, F., Leblanc, V., Grenier, S., & Doucet, P. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00767.x · Cited by 87
Treatment of Panic and Agoraphobia
Mattick, R. P., Andrews, G., Hadži-Pavlović, D., & Christensen, H. M. (1990) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199009000-00003 · Cited by 87
Heldt, E., Manfro, G. G., Kipper, L., Blaya, C., Maltz, S., Isolan, L., Hirakata, V. N., & Otto, M. W. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000067188 · Cited by 87
Mavissakalian, M., & Perel, J. M. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.49.4.318 · Cited by 86
Bouwer, C., & Stein, D. J. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00182-1 · Cited by 86
A Placebo-Controlled Trial of Bupropion SR in the Treatment of Chronic Posttraumatic Stress Disorder
Becker, M. E., Hertzberg, M. A., Moore, S. D., Dennis, M. F., Bukenya, D., & Beckham, J. C. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318032eaed · Cited by 86
James, I. M., & Savage, I. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90599-4 · Cited by 86
Sheehan, D. V., Raj, A. B., Harnett-Sheehan, K., Soto, S., & Knapp, E. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03405.x · Cited by 86
Behaviour therapy for obsessive—compulsive disorder: a decade of progress
Marks, I. (1997) · The Canadian Journal of Psychiatry · doi:10.1177/070674379704201002 · Cited by 85
Smits, J. A. J., Powers, M. B., Buxkamper, R., & Telch, M. J. (2006) · Behaviour Research and Therapy · doi:10.1016/j.brat.2006.01.001 · Cited by 85
Efficacy and Tolerability of Controlled-Release Paroxetine in the Treatment of Panic Disorder
Sheehan, D. V., Burnham, D. B., Iyengar, M. K., Perera, P., & Paxil CR Panic Disorder Study Group (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0105 · Cited by 85
Buspirone augmentation of fluoxetine in obsessive-compulsive disorder
Markovitz, P. J., Stagno, S. J., & Calabrese, J. R. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.6.798 · Cited by 85
Lack of Efficacy of a New Antidepressant (Bupropion) in the Treatment of Panic Disorder with Phobias
Sheehan, D. V., Davidson, J. R. T., Manschreck, T. C., & Fleet, J. V. W. (1983) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198302000-00006 · Cited by 85
Walker, J. R., Van Ameringen, M. A., Swinson, R., Bowen, R. C., Chokka, P. R., Goldner, E., Johnston, D. C., Lavallie, Y.-J., Nandy, S., Pecknold, J. C., et al. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00009 · Cited by 84 · cited 1×
“2001) and a 24-week relapse prevention study (Walker et al. 2000) following a 20-week DBPC study (van Ameringen et al.”
BackgroundComparison of Buspirone and Diazepam in Generalized Anxiety Disorder
Jacobson, A. F., Dominguez, R. A., Goldstein, B. J., & Steinbook, R. M. (1985) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1985.tb03430.x · Cited by 84
The association of alcoholism and anxiety
Brady, K. T., & Lydiard, R. B. (1993) · Psychiatric Quarterly · doi:10.1007/bf01065866 · Cited by 84
Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder
Enkelmann, R. (1991) · Psychopharmacology · doi:10.1007/bf02244440 · Cited by 84
A controlled trial of treatments for generalized anxiety
Lindsay, W. R., Gamsu, C. V., McLaughlin, E., Hood, E. M., & Espie, C. A. (1987) · British Journal of Clinical Psychology · doi:10.1111/j.2044-8260.1987.tb00718.x · Cited by 83
López-Ibor, J. J., Saíz, J., Cottraux, J. A., Note, I. D., Viñas, R., Bourgeois, M., Hernández, M., & Gómez-Pérez, J. C. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(95)00071-v · Cited by 83
Risperidone augmentation in refractory obsessive—compulsive disorder: an open-label study
Pfanner, C., Marazziti, D., Dell’Osso, L., Presta, S., Gemignani, A., Milanfranchi, A., & Cassano, G. B. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200015050-00007 · Cited by 83
Mirtazapine for Obsessive-Compulsive Disorder
Koran, L. M., Gamel, N. N., Choung, H. W., Smith, E. H., & Aboujaoude, E. N. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0415 · Cited by 83
Sheehan, D. V., Davidson, J., Manschreck, T. C., & Fleet, J. V. W. (1983) · PubMed · Cited by 82
Connor, K. M., Davidson, J. R. T., Weisler, R. H., Zhang, W., & Abraham, K. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0265-3 · Cited by 82
Venlafaxine for panic disorder: results from a double-blind, placebo-controlled study.
Pollack, M. H., Worthington, J. J., Otto, M. W., Maki, K. M., Smoller, J. W., Manfro, G. G., Rudolph, R. L., & Rosenbaum, J. F. (1996) · PubMed · Cited by 82
Nelson, J., & Chouinard, G. (1999) · PubMed · Cited by 81
Munjack, D. J., Crocker, B., CABE, D. D., Brown, R. A., USIGLI, R., Zulueta, A., McManus, M., McDowell, D. E., Palmer, R., & Leonard, M. D. (1989) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198902000-00005 · Cited by 81
Paroxetine Open‐Label Treatment of Pediatric Outpatients With Obsessive‐Compulsive Disorder
Rosenberg, D. R., STEWART, C. M., Fitzgerald, K. D., TAWILE, V., & CARROLL, E. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199909000-00024 · Cited by 81
Treatment of depression in patients with heart disease
Roose, S. P. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00320-2 · Cited by 81
Fitzgerald, K. D., STEWART, C. M., TAWILE, V., & Rosenberg, D. R. (1999) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1999.9.115 · Cited by 81
An Open Trial of Topiramate in the Treatment of Generalized Social Phobia
Ameringen, M. V., Mancini, C., Pipe, B., Oakman, J. M., & Bennett, M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1213 · Cited by 80
Sertraline treatment of panic disorder: results of a long-term study
Rapaport, M. H., Wolkow, R., Rubin, A., Hackett, E., Pollack, M., & Ota, K. Y. (2001) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2001.00263.x · Cited by 79
Panic Disorder: Long-Term Pharmacotherapy and Discontinuation
Rickels, K., & Schweizer, E. E. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199812001-00004 · Cited by 79
Asnis, G. M., Hameedi, F. A., Goddard, A. W., Potkin, S. G., Black, D. W., Jameel, M., Desagani, K., & Woods, S. W. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00265-7 · Cited by 79
Treatment of anxiety and depressive disorders in patients with cardiovascular disease
Davies, S., Jackson, P., Potokar, J. P., & Nutt, D. (2004) · BMJ · doi:10.1136/bmj.328.7445.939 · Cited by 79
Martényi, F., & Soldatenkova, V. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.10.007 · Cited by 79
Lörch, B., Graf-Morgenstern, M., Hautzinger, M., Schlegel, S., Hain, C., Sandmann, J., & Benkert, O. (1999) · The British Journal of Psychiatry · doi:10.1192/bjp.174.3.205 · Cited by 79
Clomipramine versus Phenelzine in Obsessive–Compulsive Disorder: A Controlled Clinical Trial
Vallejo, J., Olivares, J., Marcos, T., Bulbena, A., & Menchón, J. M. (1992) · The British Journal of Psychiatry · doi:10.1192/bjp.161.5.665 · Cited by 78
Handbook of Depression and Anxiety
(2003) · CRC Press eBooks · doi:10.3109/9780203911822 · Cited by 78
Power, K., Simpson, R., Swanson, V., & Wallace, L. A. (1990) · Europe PMC (PubMed Central) · Cited by 77
Efficacy of cognitive-behavioral and pharmacological treatments for children with social anxiety
Segool, N. K., & Carlson, J. S. (2007) · Depression and Anxiety · doi:10.1002/da.20410 · Cited by 77
Long-term Outcome After Acute Treatment with
Pollack, M. H., Otto, M. W., Tesar, G. E., COHEN, L. S., Meltzer-Brody, S. E., & Rosenbaum, J. F. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199308000-00005 · Cited by 77
Clomipramine Treatment of Agoraphobic Women: An Eight-Week Controlled Trial
Johnston, D. G., Troyer, I. E., & Whitsett, S. F. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290073009 · Cited by 77
Michelson, L. K., MAVISSAKALIAN, M. R., & Marchione, K. E. (1988) · Behavior Therapy · doi:10.1016/s0005-7894(88)80035-2 · Cited by 77
Pharmacotherapy for obessive-compulsive disorder
Greist, J. H., & Jefferson, J. W. (1998) · The British Journal of Psychiatry · doi:10.1192/s0007125000297912 · Cited by 77
An Open-Label Study of Levetiracetam for the Treatment of Social Anxiety Disorder
Simon, N. M., Worthington, J. J., Doyle, A., Hoge, E. A., Kinrys, G., Fischmann, D., Link, N., & Pollack, M. H. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0909 · Cited by 76
Treatment of obsessive-compulsive disorder in children and adolescents.
Rapoport, J. L., & Inoff‐Germain, G. (2000) · PubMed · Cited by 76
Cognitive Behavior Therapy versus Supportive Therapy in Social Phobia: A Randomized Controlled Trial
Cottraux, J., Note, I., Albuisson, E., Yao, S. N., Note, B., Mollard, E., Bonasse, F., Jalenques, I., Guérin, J., & Coudert, A. J. (2000) · Psychotherapy and Psychosomatics · doi:10.1159/000012382 · Cited by 75
Clonazepam in the Treatment of Panic Disorder With or Without Agoraphobia
Rosenbaum, J. F., Moroz, G., & Bowden, C. L. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199710000-00008 · Cited by 75
Fluvoxamine-Controlled Release Formulation for the Treatment of Generalized Social Anxiety Disorder
Davidson, J. R. T., Yaryura-Tobias, J. A., DuPont, R. L., Stallings, L., Barbato, L. M., van der Hoop, R. G., & Li, D. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000106222.36344.96 · Cited by 75
Pollack, M. H., Mangano, R. M., Entsuah, R., Tzanis, E. L., Simon, N. M., & Zhang, Y. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0821-0 · Cited by 75
Citalopram in the treatment of obsessive‐compulsive disorder: an open pilot study
Koponen, H., Lepola, U. M., Leinonen, E. V. J., Jokinen, R., Penttinen, J., & Turtonen, J. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb09927.x · Cited by 75
High-dose escitalopram for the treatment of obsessive–compulsive disorder
Rabinowitz, I., Baruch, Y., & Barak, Y. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3282f0f0c5 · Cited by 74
Clonazepam as an Augmenting Agent in the Treatment of Childhood-Onset Obsessive-Compulsive Disorder
Leonard, H. L., Topol, D., Bukstein, O. G., Hindmarsh, D. J., Allen, A. J., & Swedo, S. E. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199407000-00003 · Cited by 74
CONGENITAL MALFORMATIONS AND MATERNAL CONSUMPTION OF BENZODIAZEPINES: A CASE‐CONTROL STUDY
Laegreid, L. M., Olegård, R., CONRADI, N. G., Hagberg, G., Wahlström, J., & Abrahamsson, L. (1990) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1990.tb16962.x · Cited by 74
Stein, D. J., Cameron, A., Amrein, R., & Montgomery, S. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200207000-00002 · Cited by 74
Fluvoxamine and sleep disturbances in posttraumatic stress disorder
Neylan, T. C., Metzler, T. J., Schoenfeld, F. B., Weiss, D. S., Lenoci, M., Best, S. R., Lipsey, T. L., & Marmar, C. R. (2001) · Journal of Traumatic Stress · doi:10.1023/a:1011100420978 · Cited by 73
Antiandrogenic treatment of obsessive‐compulsive neurosis
Casas, M., Álvarez, E., Duro, P., García-Ribera, C., Udina, C., Velat, A., Abella, D., Rodrı́guez-Espinosa, J., Salva, P., & Jané, F. (1986) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1986.tb10591.x · Cited by 73
Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder
Book, S. W., Thomas, S. E., Randall, P. K., & Randall, C. L. (2007) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2007.03.001 · Cited by 73
Westenberg, H. G. M., Stein, D. J., Yang, H., Li, D., & Barbato, L. M. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000104906.75206.8b · Cited by 73
Simon, N. M., Connor, K. M., LeBeau, R. T., Hoge, E. A., Worthington, J. J., Zhang, W., Davidson, J. R. T., & Pollack, M. H. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1087-x · Cited by 72
Sertraline Treatment for Generalized Anxiety Disorder
Brawman‐Mintzer, O., Knapp, R. G., Rynn, M. A., Carter, R. E., & Rickels, K. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0603 · Cited by 72
A Double-Blind Combination Study of Clonazepam with Sertraline in Obsessive-Compulsive Disorder
Crockett, B. A., Churchill, E., & Davidson, J. R. T. (2004) · Annals of Clinical Psychiatry · doi:10.1080/10401230490486972 · Cited by 72
Tenneij, N. H., van Megen, H. J. G. M., Denys, D. A. J. P., & Westenberg, H. G. M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0913 · Cited by 71
Citalopram for treatment-resistant obsessive-compulsive disorder
Pallanti, S., Quercioli, L., Paiva, R. S., & Koran, L. M. (1999) · European Psychiatry · doi:10.1016/s0924-9338(99)80725-1 · Cited by 71
An open trial of moclobemide in the treatment of post-traumatic stress disorder
Neal, L. A., Shapland, W., & Fox, C. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199707000-00008 · Cited by 71
Cox, B. J., Endler, N. S., Lee, P. S., & Swinson, R. P. (1992) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/0005-7916(92)90034-g · Cited by 71
Moroz, G., & Rosenbaum, J. F. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0907 · Cited by 70
Treatment with Selective Serotonin Reuptake Inhibitors in the Third Trimester of Pregnancy
Nordeng, H., & Spigset, O. (2005) · Drug Safety · doi:10.2165/00002018-200528070-00002 · Cited by 70
Francobandiera, G. (2001) · The Canadian Journal of Psychiatry · doi:10.1177/070674370104600408 · Cited by 70
Richter, E. O., Davis, K. D., Hamani, C., Hutchison, W. D., Dostrovsky, J. O., & Lozano, A. M. (2004) · Neurosurgery · doi:10.1227/01.neu.0000108644.42992.95 · Cited by 69 · cited 1×
“2003; Rück, 2006; Skoog and Skoog 1999), cingulotomy (Baer et al. 1995; Dougherty et al. 2002; Jenike et al. 1991a; Kim et al. 2003; Richter et al. 2004), limbic leucotomy (Cumming et al.”
Background
Research works printed but not linked: 116
- Altshuler LL, 2001, Postgrad Med, 1
- Amore M, 1999, Hum Psychopharmacol Clin Exp, 14, 435, 10.1002/(SICI)1099-1077(199908)14:6<435::AID-HUP109>3.0.CO;2-B · doi:10.1002/(sici)1099-1077(199908)14:6<435::aid-hup109>3.0.co;2-b
- Bakish D, 1996, Psychopharmacol Bull, 32, 135
- Ballenger JC, 2001, J Clin Psychiatry, 62, 53
- Bandelow B, 2004, Br J Psychiatry, 184, 271, 10.1192/bjp.184.3.271 · DOI
- Bandelow B, 2002, Eur Neuropsychopharmacol, 12, S364, 10.1016/S0924-977X(02)80585-5 · doi:10.1016/s0924-977x(02)80585-5
- Bradwejn J, 1993, Can J Psychiatry, 38, S109
- Braun P, 1990, J Clin Psychiatry, 51, 236
- Bystritsky A, 2008, Psychopharmacol Bull, 41, 46
- 10.3109/10401239909147053 · doi:10.3109/10401239909147053
- Chao IL, 2004, Pharmacopsychiatry, 37, 239, 10.1055/s-2004-832600 · DOI
- Charney DS, 1989, J Clin Psychiatry, 50, 418
- Charney DS, 1986, J Clin Psychiatry, 47, 580
- Chouinard G, 1990, Psychopharmacol Bull, 26, 279
- 10.3109/10401230490281609 · doi:10.3109/10401230490281609
- Davis LL, 2008, Psychopharmacol Bull, 41, 8
- DeVeaugh-Geiss J, 1989, Psychopharmacol Bull, 25, 36
- Dieleman GC, 2008, Tijdschr Psychiatr, 50, 43
- Dunner DL, 1986, J Clin Psychiatry, 47, 458
- Eriksson T, 2007, Int Clin Psychopharmacol, 22, 57
- Feighner JP, 1987, J Clin Psychiatry (Suppl), 48, 3
- Feighner JP, 1982, J Clin Psychiatry, 43, 103
- Feltner DE, 2003, J Clin Psychopharmacol, 23, 240
- Ferreri M, 1994, Encéphale, 20, 785
- 10.1037/0022-006X.65.6.1026 · doi:10.1037/0022-006x.65.6.1026
- Fesler FA, 1991, J Clin Psychiatry, 52, 361
- Foa EB, 2000, J Clin Psychiatry, 61, 43
- Frommberger U, 2004, Fortschr Neurol Psychiatr, 72, 411, 10.1055/s-2004-818455 · doi:10.1055/s-2004-818455
- Gelpin E, 1996, J Clin Psychiatry, 57, 390
- Gruber RP, 1971, Dis Nerv Syst, 32, 180
- Hamner MB, 2001, Ann Clin Psychiatry, 13, 141, 10.3109/10401230109148960 · DOI
- 10.3109/10401230009147096 · DOI · Paper page
- Hoehn-Saric R, 1988, J Clin Psychiatry, 49, 293
- Hoffart A, 1993, J Clin Psychiatry, 54, 481
- 10.1037/0022-006X.72.3.393 · DOI
- Hofmann SG, 2008, J Clin Psychiatry, e1
- Husain MM, 1993, Am J Psychiatry, 150, 1899
- Jenike MA, 1991, J Clin Psychiatry, 52, 13
- Khanna S, 1988, Convuls Ther, 4, 314
- Klerman GL, 199, Social Morbidity Health Care Utilization J, 265, 742
- Kocabasoglu N, 2004, Eur Neuropsychopharmacol, 14, S304, 10.1016/S0924-977X(04)80382-1 · doi:10.1016/s0924-977x(04)80382-1
- Koran LM, 2007, Am J Psychiatry, 164, 5
- Lee C, 2002, J Clin Psychol Psychother, 58, 1071
- Lenox-Smith AJ, 2003, Br J Gen Pract, 53, 772
- Li D, 2001, J Psychiatry Neurosci, 26, 190
- Lidren DM, 1994, J Consult Clin Psychol, 62, 865, 10.1037/0022-006X.62.4.865 · DOI · Paper page
- Liebowitz MR, 1988, J Clin Psychiatry, 49, 252
- 10.1002/(SICI)1520-6394(1999)10:3%3C89::AID-DA1%3E3.0.CO;2-5 · doi:10.1002/(sici)1520-6394(1999)10:3<89::aid-da1>3.0.co;2-5
- Livingston MG, 1994, Br J Hosp Med, 51, 281
- Lopes AC, 2008, Biol Psychiaty, 63, 131s, 10.1016/j.biopsych.2007.11.007 · doi:10.1016/j.biopsych.2007.11.007
- López-Ibor JJ, 1975, Neurological treatment in psychiatry, pain and epilepsy, 151
- Lum M, 1990, Biol Psychiatry :A, 27, 164
- Maletzky B, 1994, Convuls Ther, 10, 34
- Marazziti D, 1999, Am J Psychiatry, 156, 1834, 10.1176/ajp.156.11.1834-a · doi:10.1176/ajp.156.11.1834-a
- Marmar CR, 1996, J Clin Psychiatry, 57, 66
- Mavissakalian M, 1983, Psychopharmacol Bull, 19, 116
- Mavissakalian M, 1986, J Clin Psychol, 47, 117
- Meibach RC, 1987, J Clin Psychiatry, 48, 355
- Misri S, 2000, Can Family Phys, 46, 626
- Mohlman J, 2003, Am J Geriatr Psychiatry, 11, 24
- Montoya A, 2002, Neurosurgery, 50, 1043
- Munjack DJ, 1989, J Clin Psychopharmacol, 9, 22
- Munjack DJ, 1990, J Clin Psychiatry, 51, 35
- Nelson J, 1999, Can Soc Clin Pharmacol, 6, 69
- Neylan TC, 2006, Am J Psychiatry, 163, 2186, 10.1176/ajp.2006.163.12.2186 · doi:10.1176/ajp.2006.163.12.2186
- Nicolini H, 2008, Psychol Med, 1
- NIMH 1976. National Institute of Mental Health. 028 CGI. Clinical Global Impressions. In: Guy E, ECDEU Assessment manual for psychopharmacology. Revised edition. Rockville, MD: NIMH. p 217–222.
- Noyes R, 1996, J Clin Psychiatry, 57, 349
- Nutt DJ, 1998, J Clin Psychiatry, 59, 4
- Ontiveros A, 1992, J Psychiatry Neurosci, 17, 78
- Pastrana Jiménez JI, 2007, Actas Esp Psiquiatr, 35, 351
- Pigott TA, 1992, J Clin Psychopharmacol, 12, 11
- Pollack MH, 2003, Psychopharmacol Bull, 37, 53
- Pollack MH, 1994, J Clin Psychiatry, 55, 200
- Pollack MH, 1996, Psychopharmacol Bull, 32, 667
- Pollack MH, 1997, J Clin Psychiatry, 58, 19
- Pols H, 1993, Acta Psychiatr Belg, 93, 169
- Power KG, 1990, Br J Gen Pract, 40, 289
- Prasko J, 2006, Neuroendocrinol Lett, 27, 473
- Prasko J, 2006, Neuroendocrinol Lett, 27, 327
- 10.1034/j.1600-0447.2001.00263.x · DOI · Paper page
- Ravizza L, 1996, Psychopharmacol Bull, 32, 677
- 10.1037/0022-006X.70.4.86 · doi:10.1037/0022-006x.70.4.86
- Rickels K, 1982, J Clin Psychiatry, 43, 81
- Riddle MA, 1996, Psychopharmacol Bull, 32, 399
- Rizley R, 1986, Psychopharmacol Bull, 22, 167
- Rothbaum B, 1997, Bull Menninger Clinic, 61, 317
- Rothbaum BO, 2008, J Clin Psychiatry, e1
- Rück C, 2006, Capsulotomy in anxiety disorders [thesis]
- 10.1176/appi.ajp.164.2.290 · DOI
- 10.1002/da.20271 · DOI
- Sachdev P, 1995, J Nerv Ment Dis, 183, 408, 10.1097/00005053-199506000-00010 · doi:10.1097/00005053-199506000-00010
- 10.1345/aph.1C040 · doi:10.1345/aph.1c040 · Paper page
- Saxena S, 1996, J Clin Psychiatry, 57, 303
- Seedat S, 2004, J Clin Psychiatry, 65, 244
- Shader RI, 1993, New Engl J Med, 13, 1398
- Sharp DM, 1997, Br J Gen Pract, 47, 150
- Simon NM, 2003, Psychopharmacol Bull, 37, 66
- Simon NM, 2008, J Clin Psychiatry, e1
- Stein DJ, 1999, S Afr Med J, 89, 402
- 10.3109/10401230600948431 · doi:10.3109/10401230600948431
- Stein DJ, 2007, Eur Neuropsychophar17(Suppl, 4, S509, 10.1016/S0924-977X(07)70784-8 · doi:10.1016/s0924-977x(07)70784-8
- Strand M, 1990, J Clin Psychiatry (Suppl), 51, 40
- Telch MJ, 1995, J Consult Clin Psychol, 63, 823, 10.1037/0022-006X.63.5.823 · doi:10.1037/0022-006x.63.5.823
- Tesar GE, 1991, J Clin Psychiatry, 52, 69
- Tiffon L, 1994, J Clin Psychiatry, 55, 66
- Todorov C, 2000, Can J Psychiatry, 45, 257, 10.1177/070674370004500304 · doi:10.1177/070674370004500304
- Turner SM, 1994, J Consult Clin Psychol, 62, 350, 10.1037/0022-006X.62.2.350 · DOI · Paper page
- van Ameringen M, 1993, J Clin Psychiatry, 54, 27
- van der Kolk BA, 1994, J Clin Psychiatry, 55, 517
- Wetherell JL, 2003, J Consult Clin Psychol, 71, 31, 10.1037/0022-006X.71.1.31 · DOI · Paper page
- WHO, 1991, Clinical Descriptions and Diagnostic Guidelines
- Woodman CL, 1994, J Clin Psychiatry, 55, 134
- Worthington JJ, 1998, Psychopharmacol Bull, 34, 199
- Zitterl W, 1999, Wien Klin Wochenschr, 111, 439
- Zohar J, 2006, Obsessive-compulsive disorder and comorbidity, 79
Cited by
Epidemiology of anxiety disorders in the 21st century
Bandelow, B., & Michaelis, S. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.3/bbandelow · Cited by 2,079
Self-citationStein, D. J., Costa, D. L. C., Lochner, C., Miguel, E. C., Reddy, Y. C. J., Shavitt, R. G., van den Heuvel, O. A., & Simpson, H. B. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0102-3 · Cited by 895
Treatment of anxiety disorders
Bandelow, B., Michaelis, S., & Wedekind, D. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/bbandelow · Cited by 811
Self-citationObsessive-compulsive disorder: An integrative genetic and neurobiological perspective
Pauls, D. L., Abramovitch, A., Rauch, S. L., & Geller, D. A. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3746 · Cited by 793
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676
Self-citation
Metadata
- Authors
- Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., & WFSBP TASK FORCE ON TREATMENT GUIDE
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2008-01
- Volume
- 9
- Issue
- 4
- Pages
- 248-312
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W1966065460
- Cited by
- 854
- References
- 826
- FWCI
- 73.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.